No headlines found.
Cencora Announces Leadership Succession Plan
Business Wire (Tue, 12-Mar 8:30 AM ET)
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
Business Wire (Wed, 7-Feb 6:26 PM ET)
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
Business Wire (Wed, 7-Feb 6:16 PM ET)
Cencora Closes $500 Million Senior Notes Offering
Business Wire (Wed, 7-Feb 1:11 PM ET)
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
Business Wire (Mon, 5-Feb 6:18 PM ET)
Cencora Reports Fiscal 2024 First Quarter Results
Business Wire (Wed, 31-Jan 6:30 AM ET)
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
Business Wire (Thu, 4-Jan 4:30 PM ET)
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Cencora trades on the NYSE stock market under the symbol COR.
As of March 28, 2024, COR stock price declined to $240.98 with 817,948 million shares trading.
COR has a beta of 0.20, meaning it tends to be less sensitive to market movements. COR has a correlation of 0.03 to the broad based SPY ETF.
COR has a market cap of $48.06 billion. This is considered a Large Cap stock.
Last quarter Cencora reported $72 billion in Revenue and $3.28 earnings per share. This beat revenue expectation by $3 billion and exceeded earnings estimates by $.39.
The top ETF exchange traded funds that COR belongs to (by Net Assets): VTI, VOO, VO, SPY, COWZ.
COR support price is $242.67 and resistance is $246.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COR stock will trade within this expected range on the day.